7th Mar 2011 16:48
Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons
Following a re-valuation of the cash element of the notional investment held within the US Retirement Savings Plan ("The Plan"), which is notionally held in GSK Ordinary share ADRs, the Administrators of the Plan notified GlaxoSmithKline plc and the under-mentioned persons on 7 March 2011 of an increase in the notional allocation of Ordinary share ADRs on 4 March 2011 at a price of $38.48 per ADR:-
| |||||||||
This notification relates to a transaction notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a) and (c).
V A Whyte
Company Secretary
7 March 2011
Related Shares:
Glaxosmithkline